REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,033 | -17.7% | 245 | 0.0% | 0.00% | – |
| Q2 2023 | $4,898 | +24.5% | 245 | +17.8% | 0.00% | – |
| Q1 2023 | $3,933 | -24.9% | 208 | -10.0% | 0.00% | – |
| Q4 2022 | $5,239 | -34.5% | 231 | -21.2% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 293 | -42.2% | 0.00% | – |
| Q2 2022 | $13,000 | -58.1% | 507 | -45.2% | 0.00% | – |
| Q1 2022 | $31,000 | +19.2% | 926 | +18.1% | 0.00% | – |
| Q4 2021 | $26,000 | 0.0% | 784 | +24.4% | 0.00% | – |
| Q3 2021 | $26,000 | +62.5% | 630 | +56.3% | 0.00% | – |
| Q2 2021 | $16,000 | +166.7% | 403 | +117.8% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 185 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +300.0% | 185 | +374.4% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 39 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 39 | -27.8% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 54 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 54 | +50.0% | 0.00% | – |
| Q3 2018 | $3,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |